Powering the AI Revolution for Drug Discovery with High-Quality Empirical Data

Technology > AI (Artificial Intelligence)12/5/2023 6:00 PM

Go to Registration Page


The transformative impact of artificial intelligence (AI) on various industries is undeniable. However, for the biopharmaceutical industry, AI has yet to meet its full potential. In this webinar, 1859 will discuss its approach to rapidly generating high-quality, empirical, small molecule datasets, and its comparison to other approaches, like public data curation and traditional screening technology. Join this webinar to gain insights into how data disrupts the drug discovery paradigm and ultimately delivers new medicines to patients faster.


Rate This Webinar

community rating (0 votes): 
Rate or Review This Webinar




We are accelerating drug discovery to deliver treatments to patients faster. Our powerful engine integrates combinatorial chemistry, pico-scale activity-based screening, and AI, generating millions of empirical datapoints every week to evolve our models. This enables our biologists and medicinal chemists to discover novel small molecule therapeutics rapidly.